计算溶液所需的质量、体积或浓度。
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC 50 s of 12 and 1 nM against EGFR L858R and EGFR L858R/T790M , respectively.
In Vitro
Osimertinib (AZD-9291) shows similar potency to early generation tyrosine kinase inhibitor (TKIs) in inhibiting EGFR phosphorylation in EGFR cells harboring sensitising EGFR mutants including PC-9 (ex19del), H3255 (L858R) and H1650 (ex19del), with mean IC 50 values ranging from 13 to 54 nM for Osimertinib (AZD-9291). Osimertinib (AZD-9291) also potently inhibits phosphorylation of EGFR in T790M mutant cell lines (H1975 (L858R/T790M), PC-9VanR (ex19del/T790M), with mean IC 50 potency less than 15 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
The tumor-bearing mice are treated with Osimertinib (AZD-9291) (5 mg/kg/day) for one to two weeks. Within days of treatment, 5 of 5 C/L858R mice displays nearly 80% reduction in tumor volume by magnetic resonance imaging MRI after therapy with Osimertinib (AZD-9291), while 5 of 5 mice treated with vehicle shows tumor growth . Osimertinib (AZD-9291) demonstrates improved rat PK, reduced hERG affinity, and improved IGF1R margins relative to the previously described compounds, and so this compound is selected for further investigation. Osimertinib (AZD-9291) also offers an additional degree of broader chemical and profile diversity when compared to the previously described lead compounds. Upon dosing Osimertinib (AZD-9291) in three efficacy models, The comparable efficacy is observed at relatively low doses (10 mg/kg per day). The excellent efficacy is also observed when Osimertinib (AZD-9291) is dosed at 5 mg/kg per day. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:EGFR L858R 12 nM (IC 50 ) EGFR L858R/T790M 1 nM (IC 50 )
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 吲哚及其衍生物 |
| 亚类(Subclass) | N-烷基吲哚 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | N-烷基吲哚 |
| 其他上位类(Alternative Parents) | 氨基苯醚 吲哚 甲氧基苯胺 茴香醚 苯氧基化合物 二烷基芳胺 甲氧基苯 烷基芳基醚 氨基嘧啶及其衍生物 N-甲基吡咯 烷磺酸 磺酰基 有机磺酸 杂芳族化合物 甲磺酸盐 三烷基胺 羧酰亚胺酸 氮杂环化合物 仲胺 炔丙基型1,3-偶极有机化合物 碳氢化合物衍生物 有机氧化物 |
| 分子骨架(Molecular Framework) | 暂无 |
| 取代基(Substituents) | 烷烷磺酸 - 芳基醚 - 氨基酸 - 氨基苯醚 - 氨基吡啶 - 苯胺或取代苯胺 - 茴香醚 - 芳香族杂多环化合物 - 氮杂环 - 苯基化合物 - 羧酰亚胺酸 - 羧酰亚胺酸衍生物 - 二烷基芳基胺 - 乙醚 - 杂芳香族化合物 - 烃衍生物 - 吲哚 - 甲磺酸盐 - 甲氧基苯胺 - 甲氧基苯 - 单环苯基基团 - N-烷基吲哚 - N-甲基吡咯 - 有机1,3-双极性化合物 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机磺酸或其衍生物 - 有机氮化合物 - 有机氧化合物 - 有机硒化合物 - 有机磺酸或其衍生物 - 有机硫化合物 - 苯酚醚 - 苯氧基化合物 - 丙炔型1,3-双极性有机化合物 - 嘧啶 - 吡咯 - 醛基 - 取代吡咯 - 磺酰基 - 三元脂肪胺 - 三芳基胺 |
| 描述(Description) | 该化合物属于有机化合物中的正烷基吲哚类。这类化合物含有吲哚结构单元,其1位连接烷基链。 |
| 外部描述符(External Descriptors) | 暂无 |